Amphastar Pharmaceuticals Inc (AMPH)
$27.72 +2.93% Close Oct 30, 2026 Live
Amphastar Pharmaceuticals stock today
Amphastar Pharmaceuticals closed at $27.72 on October 30, 2026, up 2.93% on the day. Over the past year it returned +12.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.22 billion.
$20.00$25.00$30.00
NovJan 2026MarMayJulSep
| Period | AMPH | S&P 500 (SPY) |
|---|---|---|
| 1 month | +7.4% | -0.9% |
| 3 months | +36.0% | +2.1% |
| Year to date | +3.5% | +11.7% |
| 1 year | +12.4% | +12.4% |
| 3 years | -38.6% | +88.5% |
| 5 years | +48.4% | +76.0% |
Key statistics
- Market value
- $1.22B
- P/E (trailing)
- 16.4
- Forward P/E
- 9.9
- Price / sales
- 1.7
- 52-week range
- $16.87 to $29.40
- Next report
- Nov 5, 2026
About Amphastar Pharmaceuticals
Manufactures generic injectable pharmaceuticals and specialty pharmaceutical products.
Sector: Health Care
More on Amphastar Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue -2% in the year to Dec 2025
- Valuation: P/E history and peersP/E 16.4, median 19.1 at its last 8 year ends
- Returns: what $1,000 became$1,000 ten years ago is $1,549 today
No forecast, no recommendation. This page describes Amphastar Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.